from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1370c/-

LFCtreatmentdescriptionclass of inhibitor

-0.072

Amikacinug/mL Amikacintranslation

0.617

Cap5-10ug/mL Capreomycintranslation

0.059

Rox10-50 ug/mL Roxithromycintranslation

-0.291

SM2-5 ug/mL Streptomycintranslation

0.156

Tet5-10 ug/mL Tetracyclinetranslation

-0.315

Rif0.2-5ug/mL Rifampicintranscription

-1.052

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.265

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.832

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.752

CPZ10-50 ug/mL Chlorpromazinerespiration

0.051

Clofazimine10-13 ug/mL Clofaziminerespiration

0.244

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.585

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.198

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.876

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.451

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.633

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.667

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.361

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.132

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.607

KCN5-20 ug/mL Potassium cyaniderespiration

0.936

NaN30.2-2 mM Sodium aziderespiration

-0.520

Nigericin50 uM Nigericinrespiration

0.648

TRC10-150 ug/mL Triclosanrespiration

-1.204

TRZ10-25 ug/mL Thioridazinerespiration

1.995

Valinomycin0.5-10 uM Valinomycinrespiration

-0.359

ZnSO42 mM ZnSO4respiration

-0.388

menadione6-10 ug/mL Menadionerespiration

-0.095

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.330

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.063

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.499

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.088

NRP_1Non-replicating persistence stage 1dosRassociated

-0.428

Amp0.2mg/mL AmpicillincellWall

0.043

Cephalexin20-100 ug/mL CephalexincellWall

-0.077

Cerulenin0.32-5 ug/mL CerulenincellWall

0.854

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.239

EMB10-20 ug/mL EthambutolcellWall

-0.133

Eta12-40 ug/mL EthionamidecellWall

-0.073

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.445

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.246

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.094

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.441

BZA0.12 mg/mL BenzamidearomaticAmides

0.448

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.882

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.175

H2O24 mM hydrogen peroxideDNAdamaging

0.035

Levo10 ug/mL LevofloxacinDNAdamaging

0.177

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.884

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.340

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.126

UVUV-irradiationDNAdamaging

-2.393

ARP41-4 ug/mL Antitubercular compound ARP4?

0.344

Antimycin12.5-50 ug/mL Antimycin A?

0.012

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.364

PA_110-50 ug/mL Antitubercular compound PA-1?

0.860

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.201

PA8240.2-2 ug/mL PA-824?

0.104

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.301

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.421

Verapamil50 uM Verapamil?

0.825

mercaptoethanol2 mM 2-Mercaptoethanol?

0.212

methoxatin10-20 ug/mL Methoxatin?